Version 5.4
Mus musculus Protein: Naa20
Summary
InnateDB Protein IDBP-208699.5
Last Modified 2012-02-14 [Report errors or provide feedback]
Gene Symbol Naa20
Protein Name N(alpha)-acetyltransferase 20, NatB catalytic subunit
Synonyms 1500004D14Rik; 2900026I01Rik; AU041458; D2Ertd186e; Nat5;
Species Mus musculus
Ensembl Protein ENSMUSP00000002805
InnateDB Gene IDBG-208697 (Naa20)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 4 experimentally validated interaction(s) in this database.
They are also associated with 9 interaction(s) predicted by orthology.
Experimentally validated
Total 4 [view]
Protein-Protein 4 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 9 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0008080 N-acetyltransferase activity
GO:0016747 transferase activity, transferring acyl groups other than amino-acyl groups
Biological Process
GO:0008152 metabolic process
Cellular Component
GO:0005622 intracellular
Protein Structure and Domains
PDB ID MGI:1915127
InterPro IPR000182 GNAT domain
IPR013653 FR47-like
IPR016181 Acyl-CoA N-acyltransferase
PFAM PF00583
PF13302
PF13508
PF13673
PF13718
PF08445
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q9DB82
UniProt Splice Variant
Entrez Gene 67877
UniGene Mm.442235
RefSeq NP_080701
MGI ID
MGI Symbol Naa20
OMIM
CCDS CCDS16827
HPRD
IMGT
EMBL AK005143 AL672100 CH466519
GenPept BAB23840 EDL28488

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca